Realty Income has steadily grown its earnings and dividends over the years. The REIT has created significant value for its shareholders since its public market listing. It's in a strong position to continue growing value for its investors in the future.
A seemingly major event for credit markets has historically sparked a sizable directional move in equities.
If you're a fan of streaming services, there are no shortage of choices. Consumer Reports lists more than three dozen services of varying types, from industry leaders like Netflix and Amazon Prime to...
Ackman's team sees the price as 'extremely attractive.'
Key Points The Global X SuperDividend ETF holds 100 of the highest-yielding dividend stocks in the world. The fund has a higher risk profile. Many of its holdings either pay variable dividends or have cut their payouts in the past.
AGNC Investment has a massive 15% dividend yield. The mortgage REIT is a unique investment that requires a nuanced understanding of its lofty yield. AGNC Investment (NASDAQ: AGNC) always seems to pop up on screens for high-yield stocks.
Coca-Cola's dividend track record shows a stable business that can perform well long-term. Costco's strategy, economic moat, and growth opportunities make its prospects attractive. No matter what happens in the next few months, the stock market should produce competitive returns over many decades.
Dividend stocks are a central aspect of Buffett's success at Berkshire Hathaway.
(Bloomberg) -- For much of the year, money managers have embraced optimism and snatched up corporate bonds, sending valuations to ever more expensive levels. Now, Wall Street titans are saying it’s time to focus on how bad things can get. Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims to Become Stanford of the GulfCan Frank Gehry’s ‘Grand LA’ Make Downtown Feel Like a Neighborhood?NYC’s War on Trash Gets a Glam SquadChi
Shopify should benefit from the switch to e-commerce thanks to its strong position and competitive edge. Vertex Pharmaceuticals' expanding lineup and deep pipeline can help it overcome recent headwinds. Despite recent market volatility, buying shares of top companies that can at least match average returns through 2035 -- or do much better -- is still worth it.